Clinical Trial Update: Neoadjuvant Immune Checkpoint Inhibitor Treatment in Urothelial Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 neoadjuvant treatment using an immune checkpoint inhibitor for urothelial carcinoma. Recruitment is ongoing and n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Snippet

Sponsor: Queen Mary University of London | Conditions: Urogenital Cancer | Phase 2 | Status: RECRUITING